International Conference in Computational Intelligence |
Foundation of Computer Science USA |
ICCIA - Number 4 |
March 2012 |
Authors: Shuchi Gautam |
a8d42167-1ab8-4972-870b-7515a5215e96 |
Shuchi Gautam . Merger and Acquistion Scenerio in Pharmaceutical Industry. International Conference in Computational Intelligence. ICCIA, 4 (March 2012), 11-15.
This Paper is an attempt to study the Phenomena of merger and acquisition deals in Pharmaceutical companies. The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world. This paper also focus on the trend of merger and acquisiton deals in the pharmaceutical industry in the past 10 years.This paper also studies the motive behind the merger and acquisition deals and the reason of failures of merger and acquisition deals in pharmaceutical companies.